Safety of biologics approved for treating rheumatoid arthritis: analysis of spontaneous reports of adverse events
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Rheumatology
Link
http://link.springer.com/content/pdf/10.1007/s10067-013-2256-9.pdf
Reference29 articles.
1. Keyser FD (2011) Choice of biologic therapy for patients with rheumatoid arthritis: the infection perspective. Curr Rheumatol Rev 7(1):77–87
2. Woodrick RS, Ruderman EM (2011) Safety of biologic therapy in rheumatoid arthritis. Nat Rev Rheumatol 7(11):639–652
3. Singh JA, Wells GA, Christensen R, et al. (2011) Adverse effects of biologics: a network meta-analysis and Cochrane overview (review). Cochrane Database of Systematic Reviews Issue 2. Art. No. CD008794. doi: 10.1002/14651858.CD008794.pub2
4. Moore TJ, Cohen MR, Furberg CD (2007) Serious adverse drug events reported to the Food and Drug Administration, 1998–2005. Arch Intern Med 167(16):1752–1759
5. Giezen TJ, Mantel-Teeuwisse AK, Meyboom RH et al (2010) Mapping the safety profile of biologicals: a disproportionality analysis using the WHO adverse drug reaction database, VigiBase. Drug Saf 33(10):865–878
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Anti-TNF-α Therapy for Refractory Uveitis Associated with Behçet’s Syndrome and Sarcoidosis: A Single Center Study of 131 Patients;Ocular Immunology and Inflammation;2020-08-20
2. Synthesis and evaluation of substituted phenyl cycloalkylureas and bioisosteres as IL-6 expression inhibitors;Medicinal Chemistry Research;2020-05-19
3. Psychiatric Adverse Events Associated With Infliximab: A Cohort Study From the French Nationwide Discharge Abstract Database;Frontiers in Pharmacology;2020-04-22
4. Comparison of signal detection of tumour necrosis factor-α inhibitors using the Korea Adverse Events Reporting System Database, 2005–2016;Clinical Rheumatology;2019-11-01
5. Intensive safety monitoring program of antineoplastic medicines: A pilot study in a Portuguese oncology hospital;Journal of Oncology Pharmacy Practice;2019-05-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3